Reproductive Endocrinology — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Reproductive Endocrinology.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Reproductive Endocrinology and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Castaneda R, Tatit CP, Hurtado Andrade MD, Faubion SS, et al. Dyslipidemia across the menopause transition: Mechanisms, trajectories, and opportunities for cardiovascular prevention Maturitas, 2026.PMID 42468089
[2]Hadji P, Athanasiadis A, Brandi ML, Chakhtoura M, et al. Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS Int J Gynaecol Obstet, 2026.PMID 42464584
[3]Wanjari UR A review on molecular regulation of male reproductive hormones and signaling pathways: Emerging mechanisms and research gap Tissue Cell, 2026.PMID 42462599
[4]Xia L, Li F, Yin D, Wei T, et al. Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells J Transl Med, 2026.PMID 42458466
[5]Korneyev I A, Apolikhin O I, Babenko A Y, Bogolyubov S V, et al. [Male infertility and reproductive dysfunction: clinical aspects of the use of terms and definitions from the Russian Society of Urology guidelines] Urologiia, 2026.PMID 42417363
[6]ESHRE Good Practice in the IVF Lab Working Group, Arroyo G, Barrie A, Coticchio G, et al. ESHRE recommendations on Good Practice in the IVF laboratory† Hum Reprod, 2026.PMID 42405499
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Reproductive Endocrinology and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Castaneda R, Tatit CP, Hurtado Andrade MD, Faubion SS, et al. Dyslipidemia across the menopause transition: Mechanisms, trajectories, and opportunities for cardiovascular prevention Maturitas, 2026.PMID 42468089
[2]Hadji P, Athanasiadis A, Brandi ML, Chakhtoura M, et al. Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS Int J Gynaecol Obstet, 2026.PMID 42464584
[3]Wanjari UR A review on molecular regulation of male reproductive hormones and signaling pathways: Emerging mechanisms and research gap Tissue Cell, 2026.PMID 42462599
[4]Xia L, Li F, Yin D, Wei T, et al. Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells J Transl Med, 2026.PMID 42458466
[5]Korneyev I A, Apolikhin O I, Babenko A Y, Bogolyubov S V, et al. [Male infertility and reproductive dysfunction: clinical aspects of the use of terms and definitions from the Russian Society of Urology guidelines] Urologiia, 2026.PMID 42417363
[6]ESHRE Good Practice in the IVF Lab Working Group, Arroyo G, Barrie A, Coticchio G, et al. ESHRE recommendations on Good Practice in the IVF laboratory† Hum Reprod, 2026.PMID 42405499
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922